Literature DB >> 11435683

Microsatellite instability.

N B Atkin1.   

Abstract

Unlike aneuploidy, considered to be the cardinal feature of malignant tumors ever since the chromosomal analysis of neoplastic cells became technically feasible, a second pathway toward malignancy has emerged over the past decade that is not characterized by gross aneuploidy but, instead, by inactivation of the DNA mismatch repair system, leading to a hypermutable state in which simple repetitive DNA sequences are unstable during DNA replication. Although mutations of many of these microsatellite sequences are presumably innocuous, because they do not occur in the coding or regulatory regions of genes, other such sequences are critically located in the coding regions of genes involved in the regulation of cell growth. First discovered in the rather uncommon hereditary nonpolyposis colorectal cancer syndrome, where there is an inactivating germline mutation in one of the DNA mismatch repair genes and most of the tumors show microsatellite instability, the latter phenomenon has since been implicated in about 15% of sporadic colorectal cancers, as well as in cancers at several other sites, such as the endometrium. Tumors showing microsatellite instability are generally near-diploid, are at a low stage of development, have a favorable prognosis, and, in the colon, are commonly located on the right side. In recent years, epigenetic phenomena, including hypermethylation and loss of imprinting, have come to be recognized as having a significant bearing on the development of these tumors. Copyright 2001 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2001        PMID: 11435683     DOI: 10.1159/000056898

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  13 in total

1.  [Polymerase chain reaction in the urinary diagnosis of bladder cancer].

Authors:  W-D Beecken; D Jonas
Journal:  Urologe A       Date:  2003-03-13       Impact factor: 0.639

2.  Frameshift mutagenesis and microsatellite instability induced by human alkyladenine DNA glycosylase.

Authors:  Joanna Klapacz; Gondichatnahalli M Lingaraju; Haiwei H Guo; Dharini Shah; Ayelet Moar-Shoshani; Lawrence A Loeb; Leona D Samson
Journal:  Mol Cell       Date:  2010-03-26       Impact factor: 17.970

3.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

Review 4.  Mutational dynamics of microsatellites.

Authors:  Atul Bhargava; F F Fuentes
Journal:  Mol Biotechnol       Date:  2010-03       Impact factor: 2.695

Review 5.  A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.

Authors:  Vanessa Deschoolmeester; Marc Baay; Pol Specenier; Filip Lardon; Jan B Vermorken
Journal:  Oncologist       Date:  2010-06-28

Review 6.  Epigenomics and ovarian carcinoma.

Authors:  Leonel Maldonado; Mohammad Obaidul Hoque
Journal:  Biomark Med       Date:  2010-08       Impact factor: 2.851

7.  hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.

Authors:  Yuning Xiong; Sean C Dowdy; Norman L Eberhardt; Karl C Podratz; Shi-Wen Jiang
Journal:  Gynecol Oncol       Date:  2006-05-15       Impact factor: 5.482

8.  Comparison of three commonly used PCR-based techniques to analyze MSI status in sporadic colorectal cancer.

Authors:  Vanessa Deschoolmeester; Marc Baay; Wim Wuyts; Eric Van Marck; Paul Pelckmans; Filip Lardon; Jan B Vermorken
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

9.  Mono-nucleotide repeats (MNRs): a neglected polymorphism for generating high density genetic maps in silico.

Authors:  Helit Cohen; Yael Danin-Poleg; Cyril J Cohen; Eli Sprecher; Ariel Darvasi; Yechezkel Kashi
Journal:  Hum Genet       Date:  2004-07-01       Impact factor: 4.132

10.  Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis.

Authors:  Danushka Seneviratne; Jihong Ma; Xinping Tan; Yong-Kook Kwon; Eman Muhammad; Mona Melhem; Marie C DeFrances; Reza Zarnegar
Journal:  Gastroenterology       Date:  2014-09-20       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.